N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1′-biphenyl]-4-amine | CAS:955959-89-4

We serve N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1′-biphenyl]-4-amine CAS:955959-89-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1'-biphenyl]-4-amine

Chemical Name:N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1'-biphenyl]-4-amine
CAS.NO:955959-89-4
Synonyms:FRPBPA
N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1'-biphenyl]-4-amine
Biphenyl-4-yl-(4-dibenzofuran-4-yl-phenyl)-amine
Molecular Formula:C37H27N
Molecular Weight:485.61698
 
Specification:
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like N-(4-(9-phenyl-9H-fluoren-9-yl)phenyl)-[1,1′-biphenyl]-4-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Molecular Formula:C37H27N physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,FRPBPA Use and application,Biphenyl-4-yl-(4-dibenzofuran-4-yl-phenyl)-amine technical grade,usp/ep/jp grade.


Related News: Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.2-Fluoro-5-methylbenzonitrile manufacturer Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.4-Bromo-9H-carbazole supplier At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.Difurfurylsulfide vendor Professor Coleman told Sky News: “Unfortunately there is no vaccine and no specific therapeutics that can be used against the coronavirus.At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.